tenk.fyi

Autolus Therapeutics plc

AUTLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$75.4M

644.9% YoY

Net Income

-$287.5M

30.3% YoY

EPS

$-1.08

25.6% YoY

Cash

$104.1M

54.2% YoY

FY 2025 · As of 2025-12-31